Version 2.78

Description

Imatinib is a drug used to treat certain types of cancer. It is currently marketed by Novartis as Gleevec (USA) or Glivec (Europe/Australia) as its mesylate salt, imatinib mesilate (INN) (formerly called STI-571). It is used in treating chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs) and other cancers.

It is the first member of a new class of agents that act by specifically inhibiting a certain enzyme that is characteristic of a particular cancer cell, rather than non-specifically inhibiting and killing all rapidly dividing cells. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Wikipedia

Basic Part Properties

Part Display Name
Imatinib mesylate
Part Type
Component (Describes the core component or analyte measured)
Created On
2009-11-16
Construct for LOINC Short Name
Imatinib mesylate

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP97866-5
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP97866-5

Language Variants Get Info

Tag Language Translation
et-EE Estonian (Estonia) Imatiniibmesülaat
es-ES Spanish (Spain)  Mesilato de imatinib
it-IT Italian (Italy) Imatinib mesilato
tr-TR Turkish (Turkey) Imatinib mezilat
ru-RU Russian (Russian Federation) Иматиниб мезилат
Synonyms: Иматиниба мезилат
nl-NL Dutch (Netherlands) imatinibmesylaat
fr-BE French (Belgium) Imatinib mésylate
zh-CN Chinese (China) 甲磺酸伊马替尼
Synonyms: 甲磺酸依马替尼;伊马替尼;依马替尼;格列卫